Literature DB >> 10830173

Obstructive nephropathy.

S Klahr1.   

Abstract

Obstructive nephropathy is a relatively common entity that is treatable and often reversible. It occurs at all ages from infancy to elderly subjects. Obstructive uropathy is classified according to the degree, duration and site of the obstruction. It is the result of functional or anatomic lesions located in the urinary tract. The causes of obstructive uropathy are many. Obstruction of the urinary tract may decrease renal blood flow and the glomerular filtration rate. Several abnormalities in tubular function may occur in obstructive nephropathy. These include decreased reabsorption of solutes and water, inability to concentrate the urine and impaired excretion of hydrogen and potassium. Renal interstitial fibrosis is a common finding in patients with long-term obstructive uropathy. Several factors: macrophages, growth factors, hypoxia, cytokines are involved in the pathogenesis of interstitial fibrosis. It has been shown that ACE inhibitors ameliorate the interstitial fibrosis in animals with obstructive uropathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10830173     DOI: 10.2169/internalmedicine.39.355

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  26 in total

1.  Salt-losing crisis in infants-not always of adrenal origin.

Authors:  Bharathi Pai; Nick Shaw; Wolfgang Högler
Journal:  Eur J Pediatr       Date:  2011-08-11       Impact factor: 3.183

2.  Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin.

Authors:  Liliana Schaefer; Wasiliki Tsalastra; Andrea Babelova; Martina Baliova; Jens Minnerup; Lydia Sorokin; Hermann-Josef Gröne; Dieter P Reinhardt; Josef Pfeilschifter; Renato V Iozzo; Roland M Schaefer
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 3.  Postobstructive diuresis: pay close attention to urinary retention.

Authors:  Colin Halbgewachs; Trustin Domes
Journal:  Can Fam Physician       Date:  2015-02       Impact factor: 3.275

4.  Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissue.

Authors:  Rikke Nørregaard; Boye L Jensen; Sukru Oguzkan Topcu; Guixian Wang; Horst Schweer; Søren Nielsen; Jørgen Frøkiaer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

5.  Renal expression and urinary excretion of Na+/dicarboxylate cotransporter 1 (NaDC1) in obstructive nephropathy: a candidate biomarker for this pathology.

Authors:  Romina V Campagno; María J Severin; Evangelina C Nosetto; Anabel Brandoni; Adriana Mónica Torres
Journal:  Pflugers Arch       Date:  2018-08-23       Impact factor: 3.657

6.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

Review 7.  Transient type 1 pseudo-hypoaldosteronism: report on an eight-patient series and literature review.

Authors:  Radovan Bogdanović; Natasa Stajić; Jovana Putnik; Aleksandra Paripović
Journal:  Pediatr Nephrol       Date:  2009-11       Impact factor: 3.714

8.  Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction.

Authors:  Xiangyang Dong; Lori A Bachman; Melinda N Miller; Karl A Nath; Matthew D Griffin
Journal:  Kidney Int       Date:  2008-08-13       Impact factor: 10.612

9.  Hydronephrotic urine in the obstructed kidney promotes urothelial carcinoma cell proliferation, migration, invasion through the activation of mTORC2-AKT and ERK signaling pathways.

Authors:  Chi-Hao Chang; Jian-Ri Li; Kuo-Hsiung Shu; Yun-Ching Fu; Ming-Ju Wu
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  Differences in the development of autogenous nerves between the upper and lower urinary tract.

Authors:  Qimin Chen; Jinquan Cai; Chengren Shi; Jie Sun; Minzhi Yin; Ping Shen
Journal:  Exp Ther Med       Date:  2013-01-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.